These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 26104541)

  • 1. [Specialized clinical facilities for the treatment of highly contagious, life-threatening infectious diseases : a comparison between Germany and 15 European nations].
    Schilling S; Brodt HR
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2015 Jul; 58(7):671-8. PubMed ID: 26104541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Structural requirements for the management of patients with highly contagious life-threatening infectious diseases: update 2015].
    Grünewald T;
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2015 Jul; 58(7):662-70. PubMed ID: 26099224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolation facilities for highly infectious diseases in Europe--a cross-sectional analysis in 16 countries.
    Schilling S; Fusco FM; De Iaco G; Bannister B; Maltezou HC; Carson G; Gottschalk R; Brodt HR; Brouqui P; Puro V; Ippolito G;
    PLoS One; 2014; 9(10):e100401. PubMed ID: 25350843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biosecurity measures in 48 isolation facilities managing highly infectious diseases.
    Puro V; Fusco FM; Schilling S; Thomson G; De Iaco G; Brouqui P; Maltezou HC; Bannister B; Gottschalk R; Brodt HR; Ippolito G;
    Biosecur Bioterror; 2012 Jun; 10(2):208-14. PubMed ID: 22571373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transportation capacity for patients with highly infectious diseases in Europe: a survey in 16 nations.
    Schilling S; Maltezou HC; Fusco FM; De Iaco G; Brodt HR; Bannister B; Brouqui P; Carson G; Puro V; Gottschalk R; Ippolito G;
    Clin Microbiol Infect; 2019 Apr; 21S():e1-e5. PubMed ID: 24750421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Management of highly contagious, life-threatening infectious diseases in Germany].
    Gottschalk R
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2015 Jul; 58(7):657-61. PubMed ID: 25963639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Personal protective equipment management and policies: European Network for Highly Infectious Diseases data from 48 isolation facilities in 16 European countries.
    De Iaco G; Puro V; Fusco FM; Schilling S; Maltezou HC; Brouqui P; Gottschalk R; Bannister B; Brodt HR; Siikamaki H; Perronne C; Brantsæter AB; Fjellet AL; Ippolito G;
    Infect Control Hosp Epidemiol; 2012 Oct; 33(10):1008-16. PubMed ID: 22961020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EuroNHID checklists for the assessment of high-level isolation units and referral centres for highly infectious diseases: results from the pilot phase of a European survey.
    Fusco FM; Schilling S; Puro V; Brodt HR; Follin P; Jarhall B; Bannister B; Maltezou HC; Thomson G; Brouqui P; Ippolito G;
    Clin Microbiol Infect; 2009 Aug; 15(8):711-9. PubMed ID: 19486074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Ebola virus disease in West Africa and Germany : clinical presentation, management and practical experience with medevacuated patients in Germany].
    Schmiedel S; Kreuels B
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2015 Jul; 58(7):679-85. PubMed ID: 25963641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Infection control practices in facilities for highly infectious diseases across Europe.
    Maltezou HC; Fusco FM; Schilling S; De Iaco G; Gottschalk R; Brodt HR; Bannister B; Brouqui P; Thomson G; Puro V; Ippolito G;
    J Hosp Infect; 2012 Jul; 81(3):184-91. PubMed ID: 22648013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Framework for the design and operation of high-level isolation units: consensus of the European Network of Infectious Diseases.
    Bannister B; Puro V; Fusco FM; Heptonstall J; Ippolito G;
    Lancet Infect Dis; 2009 Jan; 9(1):45-56. PubMed ID: 19095195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparing for patients with high-consequence infectious diseases: Example of a high-level isolation unit.
    Pfäfflin F; Stegemann MS; Heim KM; Achterberg S; Pfitzner U; Götze L; Oesterhelweg L; Suttorp N; Herzog C; Stadtmann B; Uhrig A
    PLoS One; 2022; 17(3):e0264644. PubMed ID: 35239726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Barriers and facilitators to healthcare workers' adherence with infection prevention and control (IPC) guidelines for respiratory infectious diseases: a rapid qualitative evidence synthesis.
    Houghton C; Meskell P; Delaney H; Smalle M; Glenton C; Booth A; Chan XHS; Devane D; Biesty LM
    Cochrane Database Syst Rev; 2020 Apr; 4(4):CD013582. PubMed ID: 32315451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolation rooms for highly infectious diseases: an inventory of capabilities in European countries.
    Fusco FM; Puro V; Baka A; Bannister B; Brodt HR; Brouqui P; Follin P; Gjorup IE; Gottschalk R; Hemmer R; Hoepelman IM; Jarhall B; Kutsar K; Lanini S; Lyytikainen O; Maltezou HC; Mansinho K; Marti MC; Ott K; Peleman R; Perronne C; Sheehan G; Siikamakii H; Skinhoj P; Trilla A; Vetter N; Ippolito G
    J Hosp Infect; 2009 Sep; 73(1):15-23. PubMed ID: 19647337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic issues and capabilities in 48 isolation facilities in 16 European countries: data from EuroNHID surveys.
    Thiberville SD; Schilling S; De Iaco G; Fusco FM; Thomson G; Maltezou HC; Gottschalk R; Brodt RH; Bannister B; Puro V; Ippolito G; Brouqui P;
    BMC Res Notes; 2012 Sep; 5():527. PubMed ID: 23009598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Designing a biocontainment unit to care for patients with serious communicable diseases: a consensus statement.
    Smith PW; Anderson AO; Christopher GW; Cieslak TJ; Devreede GJ; Fosdick GA; Greiner CB; Hauser JM; Hinrichs SH; Huebner KD; Iwen PC; Jourdan DR; Kortepeter MG; Landon VP; Lenaghan PA; Leopold RE; Marklund LA; Martin JW; Medcalf SJ; Mussack RJ; Neal RH; Ribner BS; Richmond JY; Rogge C; Daly LA; Roselle GA; Rupp ME; Sambol AR; Schaefer JE; Sibley J; Streifel AJ; Essen SG; Warfield KL
    Biosecur Bioterror; 2006; 4(4):351-65. PubMed ID: 17238819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Risk of Not Being Ready: A Novel Approach to Managing Constant Readiness of a High-Level Isolation Unit During Times of Inactivity.
    Borromeo Flinn J; Benza JJ; Sauer LM; Sulmonte C; Hynes NA; Garibaldi BT
    Health Secur; 2020; 18(3):212-218. PubMed ID: 32559152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A 2009 cross-sectional survey of procedures for post-mortem management of highly infectious disease patients in 48 isolation facilities in 16 countries: data from EuroNHID.
    Fusco FM; Scappaticci L; Schilling S; De Iaco G; Brouqui P; Maltezou HC; Brodt HR; Bannister B; Ippolito G; Puro V;
    Infection; 2016 Feb; 44(1):57-64. PubMed ID: 26267332
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.